These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27548442)

  • 1. Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.
    Ruiz C; Kustermann S; Pietilae E; Vlajnic T; Baschiera B; Arabi L; Lorber T; Oeggerli M; Savic S; Obermann E; Singer T; Rothschild SI; Zippelius A; Roth AB; Bubendorf L
    PLoS One; 2016; 11(8):e0160807. PubMed ID: 27548442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
    Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
    Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.
    Szulkin A; Otvös R; Hillerdal CO; Celep A; Yousef-Fadhel E; Skribek H; Hjerpe A; Székely L; Dobra K
    BMC Cancer; 2014 Sep; 14():709. PubMed ID: 25253633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived cell models as preclinical tools for genome-directed targeted therapy.
    Lee JY; Kim SY; Park C; Kim NK; Jang J; Park K; Yi JH; Hong M; Ahn T; Rath O; Schueler J; Kim ST; Do IG; Lee S; Park SH; Ji YI; Kim D; Park JO; Park YS; Kang WK; Kim KM; Park WY; Lim HY; Lee J
    Oncotarget; 2015 Sep; 6(28):25619-30. PubMed ID: 26296973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between BRCA1 mRNA expression in tumor cells from malignant effusions and chemosensitivity to cisplatin in patients with metastatic malignant effusions].
    Qian XP; Liu BR; Jiang M; Hu J; Yu LX; Wang LF; Hu WJ; Zou ZY
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):457-60. PubMed ID: 21875488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Assessment of Chemosensitivity Test in Xeno-free Culture of Autologous 
Malignant Effusion Cells from Patients with Advanced Lung Adenocarcinoma].
    Chen L; Yang S; Jiang J; Zhang Y; Feng H; Cao J; Ge X; Xie W
    Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):584-9. PubMed ID: 27666547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility Technique of Low-passage
    Vinayanuwattikun C; Prakhongcheep O; Tungsukruthai S; Petsri K; Thirasastr P; Leelayuwatanakul N; Chanvorachote P
    Anticancer Res; 2019 Dec; 39(12):6981-6988. PubMed ID: 31810970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.
    Mäkelä R; Arjonen A; Härmä V; Rintanen N; Paasonen L; Paprotka T; Rönsch K; Kuopio T; Kononen J; Rantala JK
    BMC Cancer; 2020 Jun; 20(1):590. PubMed ID: 32576176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.
    Sandercock AM; Rust S; Guillard S; Sachsenmeier KF; Holoweckyj N; Hay C; Flynn M; Huang Q; Yan K; Herpers B; Price LS; Soden J; Freeth J; Jermutus L; Hollingsworth R; Minter R
    Mol Cancer; 2015 Jul; 14():147. PubMed ID: 26227951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to treat malignant pleural effusions.
    Lenker A; Mayer DK; Bernard SA
    Clin J Oncol Nurs; 2015 Oct; 19(5):501-4. PubMed ID: 26414568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.
    Liu B; Wang T; Qian X; Liu G; Yu L; Ding Y
    Cancer Lett; 2008 Sep; 268(1):166-75. PubMed ID: 18495333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells mediate malignant pleural effusion formation.
    Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
    J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas.
    Papp E; Steib A; Abdelwahab EM; Meggyes-Rapp J; Jakab L; Smuk G; Schlegl E; Moldvay J; Sárosi V; Pongracz JE
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32527872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D Culture as a Clinically Relevant Model for Personalized Medicine.
    Fong ELS; Toh TB; Yu H; Chow EK
    SLAS Technol; 2017 Jun; 22(3):245-253. PubMed ID: 28277923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Cell Dynamics in Malignant Pleural Effusions.
    Giarnieri E; Bellipanni G; Macaluso M; Mancini R; Holstein AC; Milanese C; Giovagnoli MR; Giordano A; Russo G
    J Cell Physiol; 2015 Feb; 230(2):272-7. PubMed ID: 25205557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
    Hsu LH; Soong TC; Feng AC; Liu MC
    J Thorac Oncol; 2006 Jun; 1(5):460-7. PubMed ID: 17409900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
    Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.